at Investor's Business Daily (Thu, 6:36PM)
Watson Pharmaceuticals (WPI) receives FDA approval on its Abbreviated New Drug Application for...
Watson Pharmaceuticals (WPI) receives FDA approval on its Abbreviated New Drug Application for Irbesartan Tablets, a treatment for hypertension and diabetic nephropathy. Irbesartan is the generic equivalent to Sanofi's (SNY) Avapro. The company plans to begin shipping immediately. For the 12 months ending August 31, Avapro and its generic equivalents had total U.S. sales of approximately $390M.
From other sites
at Zacks.com (Tue, 4:30PM)
at Investor's Business Daily (Tue, 3:06PM)
at CNBC.com (Jan 16, 2015)
at Investor's Business Daily (Jan 15, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs